Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol 3: 952–961
Hofman FM, Danilovs JA, Taylor CR (1984) HLA-DR (Ia)-positive dendriticlike cells in human fetal nonlymphoid tissues. Transplantation 37: 590–594
Oliver AM, Thomson AW, Sewell HF, Abramovich DR (1988) Major histocompatibility complex (MHC) class II antigen (HLA-DR, DQ, and DP) expression in human fetal endocrine organs and gut. Scand J Immunol 27: 731–737
Keever CA, Abu HM, Graf W, McFadden P, Prichard P, O’Brien J, Flomenberg N (1995) Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 15: 407–419
Vossen MT, Westerhout EM, Soderberg-Naucler C, Wiertz EJ (2002) Viral immune evasion: a masterpiece of evolution. Immunogenetics 54: 527–542
Arrode G, Boccaccio C, Lule J, Allart S, Moinard N, Abastado JP, Alam A, Davrinche C (2000) Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J Virol 74: 10018–10024
Kanakoudi-Tsakalidou F, Debonera F, Drossou-Agakidou V, Sarafidis K, Tzimouli V, Taparkou A, Kremenopoulos G (2001) Flow cytometric measurement of HLA-DR expression on circulating monocytes in healthy and sick neonates using monocyte negative selection. Clin Exp Immunol 123: 402–407
Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21: 335–376
Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106: 263–266
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18: 767–811
Larsson M, Fonteneau JF, Bhardwaj N (2001) Dendritic cells resurrect antigens from dead cells. Trends Immunol 22: 141–148
Farrar JD, Murphy KM (2000) Type I interferons and T helper development. Immunol Today 21: 484–489
Parronchi P, Mohapatra S, Sampognaro S, Giannarini L, Wahn U, Chong P, Maggi E, Renz H, Romagnani S (1996) Effects of interferon-alpha on cytokine profile,T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol 26: 697–703
Rogge L, Barberis ML, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F (1997) Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 185: 825–831
Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, Borrow P, Tough DF (2003) Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4: 1009–1015
Drijkoningen M, De Wolf-Peeters C, Van der Steen K, Moerman P, Desmet V (1987) Epidermal Langerhans’ cells and dermal dendritic cells in human fetal and neonatal skin: an immunohistochemical study. Pediatr Dermatol 4: 11–17
Fossum S (1989) The life history of dendritic leukocytes (DL). Curr Top Pathol 79: 101–124
Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F (1997) Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94: 12551–12556
De Wit D, Olislagers V, Goriely S, Vermeulen F, Wagner H, Goldman M, Willems F (2004) Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 103: 1030–1032
Borras FE, Matthews NC, Lowdell MW, Navarrete CV (2001) Identification of both myeloid CD11c+ and lymphoid CD11c− dendritic cell subsets in cord blood. Br J Haematol 113: 925–931
Teig N, Moses D, Gieseler S, Schauer U (2002) Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol 55: 453–457
Hagendorens MM, Ebo DG, Schuerwegh AJ, Huybrechs A, Van Bever HP, Bridts CH, De Clerck LS, Stevens WJ (2003) Differences in circulating dendritic cell subtypes in cord blood and peripheral blood of healthy and allergic children. Clin Exp Allergy 33: 633–639
De Wit D, Tonon S, Olislagers V, Goriely S, Bourtriaux M, Goldman M, Willems F (2003) Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 21: 277–281
Tonon S, Goriely S, Aksoy E, Pradier O, Del Giudice G, Trannoy E, Willems F, Goldman M, De Wit D (2002) Bordetella pertussis toxin induces the release of inflammatory cytokines and dendritic cell activation in whole blood: impaired responses in human newborns. Eur J Immunol 32: 3118–3125
Sorg RV, Kogler G, Wernet P (1998) Functional competence of dendritic cells in human umbilical cord blood. Bone Marrow Transplant 22Suppl 1: S52–54
Sorg RV, Kogler G, Wernet P (1999) Identification of cord blood dendritic cells as an immature CD11c-population. Blood 93: 2302–2307
Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ (1999) Reciprocal control of T helper cell and dendritic cell differentiation. Science 283: 1183–1186
Cella M, Facchetti F, Lanzavecchia A, Colonna M (2000) Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 1: 305–310
Liu YJ (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106: 259–262
Palucka K, Banchereau J (2002) How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol 14: 420–431
Cederblad B, Riesenfeld T, Alm GV (1990) Deficient herpes simplex virusinduced interferon-alpha production by blood leukocytes of preterm and term newborn infants [published erratum appears in Pediatr Res (1990) 5: 507]. Pediatr Res 27: 7–10
Neustock P, Kruse A, Bein G, Nissen S, Kirchner H (1995) Failure to detect type 1 interferon production in human umbilical cord vein endothelial cells after viral exposure. J Interferon Cytokine Res 15: 129–135
Goriely S, Vincart B, Stordeur P, Vekemans J, Willems F, Goldman M, De Wit D (2001) Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 166: 2141–2146
Lee S, Suen Y, Chang L, Bruner V, Qian J, Indes J, Knoppel E, van de Ven C, Cairo MS (1996) Decreased interleukin-12 (IL-12) from activated cord blood versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88: 645–654
Scott ME, Kubin M, Kohl S (1997) High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells. Pediatr Res 41: 547–553
Perez-Melgosa M, Ochs HD, Linsley PS, Laman JD, van Meurs M, Flavell RA, Ernst RK, Miller SI, Wilson CB (2001) Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. Eur J Immunol 31: 2373–2381
Karlsson H, Hessle C, Rudin A (2002) Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora. Infect Immun 70: 6688–6696
Glusman G, Rowen L, Lee I, Boysen C, Roach JC, Smit AF, Wang K, Koop BF, Hood L (2001) Comparative genomics of the human and mouse T cell receptor loci. Immunity 15: 337–349
Pitcher LA, van Oers NS (2003) T-cell receptor signal transmission: who gives an ITAM? Trends Immunol 24: 554–560
Hannet I, Erkeller YF, Lydyard P, Deneys V, DeBruyere M (1992) Developmental and maturational changes in human blood lymphocyte subpopulations [see comments]. Immunol Today 13: 215, 218
Garderet L, Dulphy N, Douay C, Chalumeau N, Schaeffer V, Zilber MT, Lim A, Even J, Mooney N, Gelin C et al (1998) The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 91: 340–346
Kou ZC, Puhr JS, Rojas M, McCormack WT, Goodenow MM, Sleasman JW (2000) T-Cell receptor Vbeta repertoire CDR3 length diversity differs within CD45RA and CD45RO T-cell subsets in healthy and human immunodeficiency virus-infected children. Clin Diagn Lab Immunol 7: 953–959
van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ (2000) Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 40: 336–345
D’Andrea A, Lanier LL (1998) Killer cell inhibitory receptor expression by T cells. Curr Top Microbiol Immunol 230: 25–39
Azuma M, Cayabyab M, Phillips JH, Lanier LL (1993) Requirements for CD28-dependent T cell-mediated cytotoxicity. J Immunol 150: 2091–2101
Azuma M, Phillips JH, Lanier LL (1993) CD28-T lymphocytes. Antigenic and functional properties. J Immunol 150: 1147–1159
Frenkel L, Bryson YJ (1987) Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence for decreased production in infants younger than 2 months of age. J Pediatr 111: 97–100
Wilson M, Rosen FS, Schlossman SF, Reinherz EL (1985) Ontogeny of human T and B lymphocytes during stressed and normal gestation: phenotypic analysis of umbilical cord lymphocytes from term and preterm infants. Clin Immunol Immunopathol 37: 1–12
Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van Dongen JJ (1997) Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 130: 388–393
Carballido JM, Namikawa R, Carballido-Perrig N, Antonenko S, Roncarolo MG, de Vries JE (2000) Generation of primary antigen-specific human T-and B-cell responses in immunocompetent SCID-hu mice. Nat Med 6: 103–106
Tsegaye A, Wolday D, Otto S, Petros B, Assefa T, Alebachew T, Hailu E, Adugna F, Measho W, Dorigo W et al (2003) Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians. Clin Immunol 109: 338–346
Hassan J, Reen DJ (1998) IL-7 promotes the survival and maturation but not differentiation of human post-thymic CD4+ T cells. Eur J Immunol 28: 3057–3065
Sanders ME, Makgoba MW, June CH, Young HA, Shaw S (1989) Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor-mediated activation. Eur J Immunol 19: 803–808
Horgan KJ, Van Seventer GA, Shimizu Y, Shaw S (1990) Hyporesponsiveness of “naive” (CD45RA+) human T cells to multiple receptor-mediated stimuli but augmentation of responses by co-stimuli. Eur J Immunol 20: 1111–1118
Kimachi K, Croft M, Grey HM (1997) The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells. Eur J Immunol 27: 3310–3317
Zaitseva MB, Lee S, Rabin RL, Tiffany HL, Farber JM, Peden KW, Murphy PM, Golding H (1998) CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection. J Immunol 161: 3103–3113
Liu K, Li Y, Prabhu V, Young L, Becker KG, Munson PJ, Weng N (2001) Augmentation in expression of activation-induced genes differentiates memory from naive CD4+ T cells and is a molecular mechanism for enhanced cellular response of memory CD4+ T cells. J Immunol 166: 7335–7344
Woodside DG, Long DA, McIntyre BW (1999) Intracellular analysis of interleukin-2 induction provides direct evidence at the single cell level of differential coactivation requirements for CD45RA+ and CD45RO+ T cell subsets. J Interferon Cytokine Res 19: 769–779
Hassan J, O’Neill S, O’Neill LA, Pattison U, Reen DJ (1995) Signalling via CD28 of human naive neonatal T lymphocytes. Clin Exp Immunol 102: 192–198
Hassan J, Rainsford E, Reen DJ (1997) Linkage of protein kinase C-beta activation and intracellular interleukin-2 accumulation in human naive CD4 T cells. Immunology 92: 465–471
Hassan J, Reen DJ (1997) Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation when compared with their adult counterparts. Immunology 90: 397–401
Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, Alpert AR (1986) Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 77: 860–867
Saito S, Morii T, Umekage H, Makita K, Nishikawa K, Narita N, Ichijo M, Morikawa H, Ishii N, Nakamura M et al (1996) Expression of the interleukin-2 receptor gamma chain on cord blood mononuclear cells. Blood 87: 3344–3350
Chilmonczyk BA, Levin MJ, McDuffy R, Hayward AR (1985) Characterization of the human newborn response to herpesvirus antigen. J Immunol 134: 4184–4188
Hassan J, Reen DJ (1996) Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production. Immunology 87: 604–608
Tu W, Chen S, Sharp M, Dekker C, Manganello AM, Tongson EC, Maecker HT, Holmes TH, Wang Z, Kemble G et al (2004) Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 172: 3260–3267
Chen L, Cleary AM, Lewis DB (2005) Impaired allogeneic activation and TH1 differentiation of human neonatal naive CD4 T cells. Submitted for publication
White GP, Watt PM, Holt BJ, Holt PG (2002) Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO− T cells. J Immunol 168: 2820–2827
Melvin AJ, McGurn ME, Bort SJ, Gibson C, Lewis DB (1995) Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells. Eur J Immunol 25: 426–430
Jullien P, Cron RQ, Dabbagh K, Cleary A, Chen L, Tran P, Stepick-Biek P, Lewis DB (2003) Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation. Int Immunol 15: 1461–1472
Kadereit S, Mohammad SF, Miller RE, Woods KD, Listrom CD, McKinnon K, Alali A, Bos LS, Iacobucci ML, Sramkoski MR et al (1999) Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 94: 3101–3107
Kiani A, Garcia-Cozar FJ, Habermann I, Laforsch S, Aebischer T, Ehninger G, Rao A (2001) Regulation of interferon-gamma gene expression by nuclear factor of activated T cells. Blood 98: 1480–1488
Ribeiro-do-Couto LM, Boeije LC, Kroon JS, Hooibrink B, Breur-Vriesendorp BS, Aarden LA, Boog CJ (2001) High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur J Immunol 31: 3394–3402
Schonbeck U, Libby P (2001) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58: 4–43
Brugnoni D, Airo P, Graf D, Marconi M, Lebowitz M, Plebani A, Giliani S, Malacarne F, Cattaneo R, Ugazio AG (1994) Ineffective expression of CD40 ligand on cord blood T cells may. Eur J Immunol 24: 1919–1924
Fuleihan R, Ahern D, Geha RS (1994) Decreased expression of the ligand for CD40 in newborn lymphocytes. Eur J Immunol 24: 1925–1928
Durandy A, De-Saint-Basile G, Lisowska GB, Gauchat JF, Forveille M, Kroczek RA, Bonnefoy JY, Fischer A (1995) Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 154: 1560–1568
Nonoyama S, Penix LA, Edwards CP, Lewis DB, Ito S, Aruffo A, Wilson CB, Ochs HD (1995) Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 95: 66–75
Fuleihan R, Ahern D, Geha RS (1995) CD40 ligand expression is developmentally regulated in human thymocytes. Clin Immunol Immunopathol 76: 52–58
Sato K, Nagayama H, Takahashi TA (1999) Aberrant CD3-and CD28-mediated signaling events in cord blood. J Immunol 162: 4464–4471
Splawski JB, Nishioka J, Nishioka Y, Lipsky PE (1996) CD40 ligand is expressed and functional on activated neonatal T cells. J Immunol 156: 119–127
Elliott SR, Roberton DM, Zola H, Macardle PJ (2000) Expression of the costimulator molecules, CD40 and CD154, on lymphocytes from neonates and young children. Hum Immunol 61: 378–388
Matthews NC, Wadhwa M, Bird C, Borras FE, Navarrete CV (2000) Sustained expression of CD154 (CD40L) and proinflammatory cytokine production by alloantigen-stimulated umbilical cord blood T cells. J Immunol 164: 6206–6212
Cayabyab M, Phillips JH, Lanier LL (1994) CD40 preferentially costimulates activation of CD4+ T lymphocytes. J Immunol 152: 1523–1531
Takahashi N, Imanishi K, Nishida H, Uchiyama T (1995) Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 155: 5213–5219
Takahashi N, Kato H, Imanishi K, Miwa K, Yamanami S, Nishida H, Uchiyama T (2000) Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J Clin Invest 106: 1409–1415
Langenkamp A, Messi M, Lanzavecchia A, Sallusto F (2000) Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 1: 311–316
Sato K, Kawasaki H, Morimoto C, Yamashima N, Matsuyama T (2002) An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5. J Immunol 168: 6263–6272
Berkowitz RD, Beckerman KP, Schall TJ, McCune JM (1998) CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J Immunol 161: 3702–3710
Sato K, Kawasaki H, Nagayama H, Enomoto M, Morimoto C, Tadokoro K, Juji T, Takahashi T (2001) Chemokine receptor expressions and responsiveness of cord blood T cells. J Immunol 166: 1659–1666
Christopherson Kn, Brahmi Z, Hromas R (1999) Regulation of naive fetal Tcell migration by the chemokines Exodus-2 and Exodus-3. Immunol Lett 69: 269–273
Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M, Lanzavecchia A (1999) Switch in chemokine receptor expression upon TCR stimulation homing potential for recently activated T cells. Eur J Immunol 29: 2037–2045
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A (1999) Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 401: 708–712
Baron V, Bouneaud C, Cumano A, Lim A, Arstila TP, Kourilsky P, Ferradini L, Pannetier C (2003) The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. Immunity 18: 193–204
Cleary AM, Tu W, Enright A, Giffon T, Dewaal-Malefyt R, Gutierrez K, Lewis DB (2003) Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency. J Immunol 170: 597–603
Upham JW, Lee PT, Holt BJ, Heaton T, Prescott SL, Sharp MJ, Sly PD, Holt PG (2002) Development of interleukin-12-producing capacity throughout childhood. Infect Immun 70: 6583–6588
de-Jong R, Brouwer M, Miedema F, van-Lier R-A (1991) Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation. J Immunol 146: 2088–2094
Akbar AN, Salmon M, Ivory K, Taki S, Pilling D, Janossy G (1991) Human CD4+CD45R0+ and CD4+CD45RA+ T cells synergize in response to alloantigens. Eur J Immunol 21: 2517–2522
Mescher MF (1995) Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol Rev 146: 177–210
Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van-Lier R-A (1997) Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186: 1407–1418
Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA et al (2002) Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8: 379–385
Marchant A, Appay V, Van Der Sande M, Dulphy N, Liesnard C, Kidd M, Kaye S, Ojuola O, Gillespie GM, Vargas Cuero AL et al (2003) Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 111: 1747–1755
Hermann E, Truyens C, Alonso-Vega C, Even J, Rodriguez P, Berthe A, Gonzalez-Merino E, Torrico F, Carlier Y (2002) Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100: 2153–2158
Clerici M, DePalma L, Roilides E, Baker R, Shearer GM (1993) Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest 91: 2829–2836
Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, De Groote D, Corrah T, Bennett S, Wheeler J, Huygen K et al (1999) Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 163: 2249–2255
Ota MO, Vekemans J, Schlegel-Haueter SE, Fielding K, Sanneh M, Kidd M, Newport MJ, Aaby P, Whittle H, Lambert PH et al (2002) Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination. J Immunol 168: 919–925
Vekemans J, Ota MO, Wang EC, Kidd M, Borysiewicz LK, Whittle H, McAdam KP, Morgan G, Marchant A (2002) T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination. Clin Exp Immunol 127: 495–498
Rowe J, Macaubas C, Monger T, Holt BJ, Harvey J, Poolman JT, Loh R, Sly PD, Holt PG (2001) Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function. J Infect Dis 184: 80–88
Gibson L, Piccinini G, Lilleri D, Revello MG, Wang Z, Markel S, Diamond DJ, Luzuriaga K (2004) Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8(+) T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 172: 2256–2264
Riviere Y, Buseyne F (1998) Cytotoxic T lymphocytes generation capacity in early life with particular reference to HIV. Vaccine 16: 1420–1422
Pikora CA, Sullivan JL, Panicali D, Luzuriaga K (1997) Early HIV-1 envelopespecific cytotoxic T lymphocyte responses in vertically infected infants. J Exp Med 185: 1153–1161
Park AY, Scott P (2001) Il-12: keeping cell-mediated immunity alive. Scand J Immunol 53: 529–532
Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M, Sullivan JL (2000) Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol 74: 6984–6991
Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, Sullivan JL (1995) HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 154: 433–443
Pacanowski J, Kahi S, Baillet M, Lebon P, Deveau C, Goujard C, Meyer L, Oksenhendler E, Sinet M, Hosmalin A (2001) Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood 98: 3016–3021
Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, Benaroch P (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 98: 12144–12149
Nielsen SD, Jeppesen DL, Kolte L, Clark DR, Sorensen TU, Dreves AM, Ersboll AK, Ryder LP, Valerius NH, Nielsen JO (2001) Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 98: 398–404
Badley AD, Pilon AA, Landay A, Lynch DH (2000) Mechanisms of HIV-associated lymphocyte apoptosis. Blood 96: 2951–2964
Chougnet C, Kovacs A, Baker R, Mueller BU, Luban NL, Liewehr DJ, Steinberg SM, Thomas EK, Shearer GM (2000) Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 181: 1590–1597
Chiba Y, Higashidate Y, Suga K, Honjo K, Tsutsumi H, Ogra PL (1989) Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J Med Virol 28: 133–139
Chang J, Braciale TJ (2002) Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 8: 54–60
Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381: 751–758
Ozaki K, Spolski R, Feng CG, Qi CF, Cheng J, Sher A, Morse HC, 3rd, Liu C, Schwartzberg PL, Leonard WJ (2002) A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630–1634
Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176: 154–170
Poe JC, Hasegawa M, Tedder TF (2001) CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction. Int Rev Immunol 20: 739–762
Ravetch JV, Bolland S (2001) IgG Fc receptors. Annu Rev Immunol 19: 275–290
Gupta S, Pahwa R, O’Reilly R, Good RA, Siegal FP (1976) Ontogeny of lymphocyte subpopulations in human fetal liver. Proc Natl Acad Sci USA 73: 919–922
Gathings WE, Lawton AR, Cooper MD (1977) Immunofluorescent studies of the development of pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur J Immunol 7: 804–810
Schultz C, Reiss I, Bucsky P, Gopel W, Gembruch U, Ziesenitz S, Gortner L (2000) Maturational changes of lymphocyte surface antigens in human blood: comparison between fetuses, neonates and adults. Biol Neonate 78: 77–82
Zemlin M, Schelonka RL, Bauer K, Schroeder HW, Jr (2002) Regulation and chance in the ontogeny of B and T cell antigen receptor repertoires. Immunol Res 26: 265–278
Sanz I (1991) Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol 147: 1720–1729
Mortari F, Newton JA, Wang JY, Schroeder HJ (1992) The human cord blood antibody repertoire. Frequent usage of the VH7 gene family. Eur J Immunol 22: 241–245
Silverman GJ, Sasano M, Wormsley SB (1993) Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen. J Immunol 151: 5840–5855
Padlan EA (1994) Anatomy of the antibody molecule. Mol Immunol 31: 169–217
Cuisinier AM, Fumoux F, Moinier D, Boubli L, Guigou V, Milili M, Schiff C, Fougereau M, Tonnelle C (1990) Rapid expansion of human immunoglobulin repertoire VH, V kappa, V lambda expressed in early fetal bone marrow. New Biologist 2: 689–699
Mortari F, Wang JY, Schroeder HJ (1993) Human cord blood antibody repertoire. Mixed population of VH gene segments and CDR3 distribution in the expressed C alpha and C gamma repertoires. J Immunol 150: 1348–1357
Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, Arkwright PD, Baniyash M, Brooks EG, Conley ME et al (2001) V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 97: 81–88
Schroeder HW, Jr, Ippolito GC, Shiokawa S (1998) Regulation of the antibody repertoire through control of HCDR3 diversity. Vaccine 16: 1383–1390
Gilfillan S, Bachmann M, Trembleau S, Adorini L, Kalinke U, Zinkernagel R, Benoist C, Mathis D (1995) Efficient immune responses in mice lacking N-region diversity. Eur J Immunol 25: 3115–3122
Macardle PJ, Weedon H, Fusco M, Nobbs S, Ridings J, Flego L, Roberton DM, Zola H (1997) The antigen receptor complex on cord B lymphocytes. Immunology 90: 376–382
Gagro A, McCloskey N, Challa A, Holder M, Grafton G, Pound JD, Gordon J (2000) CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40. Immunology 101: 201–209
Wedgwood JF, Weinberger BI, Hatam L, Palmer R (1997) Umbilical cord blood lacks circulating B lymphocytes expressing surface IgG or IgA. Clin Immunol Immunopathol 84: 276–282
Zheng B, Kelsoe G, Han S (1996) Somatic diversification of antibody responses. J Clin Immunol 16: 1–11
Punnonen J, Aversa GG, Vandekerckhove B, Roncarolo MG, de-Vries J-E (1992) Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells. J Immunol 148: 3398–3404
Bhat NM, Kantor AB, Bieber MM, Stall AM, Herzenberg LA, Teng NN (1992) The ontogeny and functional characteristics of human B-1 CD5+ B cells. Intern Immunol 4: 243–252
Kipps TJ, Robbins BA, Carson DA (1990) Uniform high frequency expression of autoantibody-associated crossreactive idiotypes in the primary B cell follicles of human fetal spleen. J Exp Med 171: 189–196
Antin JH, Emerson SG, Martin P, Gadol N, Ault KA (1986) Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol 136: 505–510
Griffiths CS, Patterson JA, Berger CL, Edelson RL, Chu AC (1984) Characterization of immature T cell subpopulations in neonatal blood. Blood 64: 296–300
Small TN, Keever C, Collins N, Dupont B, O’Reilly RJ, Flomenberg N (1989) Characterization of B cells in severe combined immunodeficiency disease. Hum Immunol 25: 181–193
Lydyard PM, Quartey PR, Broker B, Mackenzie L, Jouquan J, Blaschek MA, Steele J, Petrou M, Collins P, Isenberg D et al (1990) The antibody repertoire of early human B cells. I. High frequency of autoreactivity and polyreactivity. Scand J Immunol 31: 33–43
Chen ZJ, Wheeler CJ, Shi W, Wu AJ, Yarboro CH, Gallagher M, Notkins AL (1998) Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur J Immunol 28: 989–994
Calado RT, Garcia AB, Falcao RP (1999) Age-related changes of immunophenotypically immature lymphocytes in normal human peripheral blood. Cytometry 38: 133–137
Rijkers GT, Sanders EA, Breukels MA, Zegers BJ (1998) Infant B cell responses to polysaccharide determinants. Vaccine 16: 1396–1400
Jessup CF, Ridings J, Ho A, Nobbs S, Roberton DM, Macardle P, Zola H (2001) The Fc receptor for IgG (Fc gamma RII; CD32) on human neonatal B lymphocytes. Hum Immunol 62: 679–685
Parra C, Rold’an E, Brieva JA (1996) Deficient expression of adhesion molecules by human CD5— B lymphocytes both after bone marrow transplantation and during normal ontogeny. Blood 88: 1733–1740
Tasker L, Marshall-Clarke S (2003) Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA. Clin Exp Immunol 134: 409–419
Splawski J, Yamamoto K, Lipsky P (1998) Deficient interleukin-10 production by neonatal T cells does not expalin their ineffectiveness at promoting neonatal B cell differentiation. Eur J Immunol 28: 4248–4256
Huang LY, Aliberti J, Leifer CA, Segal DM, Sher A, Golenbock DT, Golding B (2003) Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent. J Immunol 171: 1441–1446
Ambrosino DM, Delaney NR, Shamberger RC (1990) Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6. J Immunol 144: 1221–1226
Peeters CC, Tenbergen-Meekes AM, Heijnen CJ, Poolman JT, Zegers JM, Rijkers GT (1992) Interferon-gamma and interleukin-6 augment the human in vitro antibody response to the Haemophilus influenzae type b polysaccharide. J Infect Dis 165(Suppl 1): S161–S162
Snapper CM, Mond JJ (1996) A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 157: 2229–2233
Buchanan RM, Arulanandam BP, Metzger DW (1998) IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J Immunol 161: 5525–5533
Snapper CM, Rosas FR, Jin L, Wortham C, Kehry MR, Mond JJ (1995) Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol 155: 5582–5589
Chelvarajan RL, Raithatha R, Venkataraman C, Kaul R, Han SS, Robertson DA, Bondada S (1999) CpG oligodeoxynucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymus-independent stimuli anti-IgM and TNP-Ficoll. Eur J Immunol 29: 2808–2818
Golding B, Muchmore AV, Blaese RM (1984) Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP Brucella abortus behaves as a T-independent type 1 antigen in humans. J Immunol 133: 2966–2971
Fink C, Miller WE Jr, Dorward B, Lospalluto J (1962) The formation of macroglobulin antibodies II. Studies on neonatal infants and older children. J Clin Invest 41: 1422–1428
Smith R, Eitzman DV (1964) The development of the immune response. Pediatrics 33: 163–183
Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, Berner R, Peters A, Boehm T, Plebani A et al (2003) Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197: 939–945
Haas KM, Hasegawa M, Steeber DA, Poe JC, Zabel MD, Bock CB, Karp DR, Briles DE, Weis JH, Tedder TF (2002) Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713–723
Peset-Llopis MJ, Harms G, Hardonk MJ, Timens W (1996) Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 97: 1015–1024
Timens W, Rozeboom T, Poppema S (1987) Fetal and neonatal development of human spleen: an immunohistological study. Immunology 60: 603–609
Thornton CA, Holloway JA, Warner JO (2002) Expression of CD21 and CD23 during human fetal development. Pediatr Res 52: 245–250
Viemann D, Schlenke P, Hammers HJ, Kirchner H, Kruse A (2000) Differential expression of the B cell-restricted molecule CD22 B lymphocytes depending upon antigen stimulation. Eur J Immunol 30: 550–559
Durandy A, De Saint BG, Lisowska-Grospierre B, Gauchat JF, Forveille M, Kroczek RA, Bonnefoy JY, Fischer A (1995) Undetectable CD40 ligand expression on T cells and low B cell. J Immunol 154: 1560–1568
Dengrove J, Lee EJ, Heiner DC, St. Geme JJ, Leake R, Baraff LJ, Ward JI (1986) IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization. Pediatr Res 20: 735–739
Smolen P, Bland R, Heiligenstein E, Lawless MR, Dillard R, Abramson J (1983) Antibody response to oral polio vaccine in premature infants. J Pediatr 103: 917–919
West DJ (1989) Clinical experience with hepatitis B vaccines. Am J Infect Control 17: 172–180
Uhr J, Dancis J, Franklin E, Finkelstein MS, Lewis EW (1962) The antibody response to bacteriophage in newborn premature infants. J Clin Invest 41: 1509–1513
Lee SS, Lo YC, Young BW, Wong KH, Lim WL (1995) A reduced dose approach to hepatitis B vaccination for low-risk newborns and preschool children. Vaccine 13: 373–376
Greenberg DP (1993) Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies. Pediatr Infect Dis J 12: 438–445
Dancis J, Osburn JJ, Kunz HW (1953) Studies of the immunology of the newborn infant. Pediatrics 12: 151–157
McFarland EJ, Borkowsky W, Fenton T, Wara D, McNamara J, Samson P, Kang M, Mofenson L, Cunningham C, Duliege AM et al (2001) Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. J Infect Dis 184: 1331–1335
Peterson J (1951) Immunization in the young infant. Response to combined vaccines: I–IV. American Journal of Diseases of Children 81: 484–491
Provenzano R, Wetterlow LH, Sullivan CL (1965) Immunization and antibody response in the newborn infant. N Engl J Med 273: 959–965
Baraff LJ, Leake RD, Burstyn DG, Payne T, Cody CL, Manclark CR, St. Geme JJ (1984) Immunologic response to early and routine DTP immunization in infants. Pediatrics 73: 37–42
Smith DH, Peter G, Ingram DL, Harding AL, Anderson P (1973) Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics 52: 637–644
Adderson EE, Shackelford PG, Quinn A, Carroll WL (1991) Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol 147: 1667–1674
Schlesinger Y, Granoff DM (1992) Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. Jama 267: 1489–1494
Granoff DM, Holmes SJ, Osterholm MT, McHugh JE, Lucas AH, Anderson EL, Belshe RB, Jacobs JL, Medley F, Murphy TV (1993) Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 168: 663–671
Siber G (1994) Pneumococcal disease: prospects for a new generation of vaccines. Science 265: 1385–1387
Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM (1996) Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 128: 649–653
Daum RS, Hogerman D, Rennels MB, Bewley K, Malinoski F, Rothstein E, Reisinger K, Block S, Keyserling H, Steinhoff M (1997) Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines. J Infect Dis 176: 445–455
Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K (1996) Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect Dis 174: 1360–1363
Eskola J, Kayhty H (1998) Early immunization with conjugate vaccines. Vaccine 16: 1433–1438
Lieberman JM, Greenberg DP, Wong VK, Partridge S, Chang SJ, Chiu CY, Ward JI (1995) Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 126: 198–205
Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA (1979) Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. American Journal of Diseases of Children 133: 1240–1243
Vahlquist B (1949) Response of infants to diphtheria immunization. Lancet 1: 16–18
Perkins F, Yetts R, Gaisfurd W (1959) Response of infants to a third dose of poliomelitis vaccine given 10 to 12 months after primary immunization. Br Med J 115: 680–682
Sullender WM, Miller JL, Yasukawa LL, Bradley JS, Black SB, Yeager AS, Arvin AM (1987) Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 155: 28–37
Burchett SK, Corey L, Mohan KM, Westall J, Ashley R, Wilson CB (1992) Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165: 813–818
Stagno S, Cloud GA (1994) Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc Natl Acad Sci USA 91: 2384–2389
Adler SP (1992) Cytomegalovirus transmission and child day care. Adv Pediatr Infect Dis 7: 109–122
Revello MG, Zavattoni M, Sarasini A, Percivalle E, Simoncini L, Gerna G (1998) Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 177: 1170–1175
Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF (1999) Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 180: 702–707
Pass R (2001) Cytomegalovirus. In: Knipe DM (ed): Fields virology. Lippincott Williams & Wilkins, Philadelphia, p. 2675
Riddell SR, Greenberg PD (2000) T-cell therapy of cytomegalovirus and human immunodeficiency virus infection. J Antimicrob Chemother 45(Suppl) T3: 35–43
Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH (1989) Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J Exp Med 169: 1199–1212
Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH (1992) Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66: 1977–1984
Polic B, Hengel H, Krmpotic A, Trgovcich J, Pavic I, Luccaronin P, Jonjic S, Koszinowski UH (1998) Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188: 1047–1054
Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ (1997) Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 99: 1739–1750
Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E et al (2001) Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 255: 27–40
Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT (2002) Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 186: 15–22
Kern F, Bunde T, Faulhaber N, Kiecker F, Khatamzas E, Rudawski IM, Pruss A, Gratama JW, Volkmer-Engert R, Ewert R et al (2002) Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 185: 1709–1716
Erkeller-Yuksel FM, Deneys V, Yuksel B, Hannet I, Hulstaert F, Hamilton C, Mackinnon H, Stokes LT, Munhyeshuli V, Vanlangendonck F (1992) Agerelated changes in human blood lymphocyte subpopulations. J Pediatr 120: 216–222
Rentenaar RJ, Gamadia LE, van DerHoek N, van Diepen FN, Boom R, Weel JF, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ (2000) Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection. J Clin Invest 105: 541–548
Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ (2003) Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 101: 2686–2692
Young JL, Ramage JM, Gaston JS, Beverley PC (1997) In vitro responses of human CD45R0brightRA-and CD45R0-RAbright T cell subsets and their relationship to memory and naive T cells. Eur J Immunol 27: 2383–2390
Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR, Maino VC (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86: 1408–1419
Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S (1988) Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 140: 1401–1407
Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG (1996) The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 70: 7569–7579
Engstrand M, Tournay C, Peyrat MA, Eriksson BM, Wadstrom J, Wirgart BZ, Romagne F, Bonneville M, Totterman TH, Korsgren O (2000) Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation 69: 2243–2250
Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274: 94–96
Adler SP (1991) Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr Infect Dis J 10: 584–590
Adler SP (1985) The molecular epidemiology of cytomegalovirus transmission among children attending a day care center. J Infect Dis 152: 760–768
Marrack P, Kappler J (1990) The staphylococcal enterotoxins and their relatives. Science 248: 705–711
Mocarski ES, Jr (2002) Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 10: 332–339
Cherry JD (1997) Measles. In: Feigin R (ed): Textbook of pediatric infectious diseases,Vol. 2. Saunders, Philadelphia
Papania M, Baughman AL, Lee S, Cheek JE, Atkinson W, Redd SC, Spitalny K, Finelli L, Markowitz L (1999) Increased susceptibility to measles in infants in the United States. Pediatrics 104: e59
Hutchins S, Markowitz L, Atkinson W, Swint E, Hadler S (1996) Measles outbreaks in the United States, 1987 through 1990. Pediatr Infect Dis J 15: 31–38
Clements CJ, Cutts FT (1995) The epidemiology of measles: thirty years of vaccination. Curr Top Microbiol Immunol 191: 13–33
Aaby P, Clements J, Orinda V (1991) Mortality from measles: measuring the impact. Expanded Programme on Immunization, Geneva
Samb B, Aaby P, Whittle HC, Seck AM, Rahman S, Bennett J, Markowitz L, Simondon F (1995) Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal. Pediatr Infect Dis J 14: 203–209
Maldonado YA, Lawrence EC, DeHovitz R, Hartzell H, Albrecht P (1995) Early loss of passive measles antibody in infants of mothers with vaccine-induced immunity. Pediatrics 96: 447–450
Markowitz LE, Albrecht P, Rhodes P, Demonteverde R, Swint E, Maes EF, Powell C, Patriarca PA (1996) Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Pediatrics 97: 53–58
Kumar ML, Johnson CE, Chui LW, Whitwell JK, Staehle B, Nalin D (1998) Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers. Vaccine 16: 2047–2051
Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y (1998) Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. Jama 280: 527–532
Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM (2001) Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. J Infect Dis 184: 817–826
Gans HA, Maldonado Y, Yasukawa LL, Beeler J, Audet S, Rinki MM, DeHovitz R, Arvin AM (1999) IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. J Immunol 162: 5569–5575
Siegrist CA, Caordova M, Brandt C, Barrios C, Berney M, Tougne C, Kovarik J, Lambert PH (1998) Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 16: 1409–1414
Aaby P, Bukh J, Leerhoy J, Lisse IM, Mordhorst CH, Pedersen IR (1986) Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J Infect Dis 154: 858–863
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Birkhäuser Verlag Basel/Switzerland
About this chapter
Cite this chapter
Arvin, A.M., Lewis, D.B. (2005). Vaccination in the context of immunological immaturity. In: Kaufmann, S.H., Lambert, PH. (eds) The Grand Challenge for the Future. Birkhäuser Advances in Infectious Diseases BAID. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7381-4_7
Download citation
DOI: https://doi.org/10.1007/3-7643-7381-4_7
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-7175-3
Online ISBN: 978-3-7643-7381-8
eBook Packages: MedicineMedicine (R0)